Readers' Picks: TheStreet.com's Top 10

James Altucher suggests some Dow laggards, and Jim Jubak looks at innovators for your portfolio.
Author:
Publish date:

In case you missed them, here are the 10 most widely read articles and widely viewed videos on TheStreet.com for the past three days (as of March 28). James Altucher suggests some Dow laggards, and Jim Jubak looks at innovators for your portfolio.

1.

Wednesday's Analysts' Upgrades and Downgrades

by TSC Staff, published March 28 at 9:04 a.m. EDT.

Who made what calls.

2.

Stockpickr: Trade Like Goldman Sachs

by James Altucher, published March 27 at 7:37 a.m. EDT.

It has valuable trading ideas. Here's how to find them.

3.

Morgan Looks to Unload New Century Loans

by Laurie Kulikowski, published March 26 at 5:16 p.m. EDT.

The move could signal that a bankruptcy filing is imminent at the lender.

4.

Construction Boom: Built-In Subprime Risk

by Jim Cramer, published March 26 at 2:07 p.m. EDT.

A lot of this problem is known, which means the market is already discounting it.

5.

10 Innovators for Your Portfolio

by Jim Jubak, published March 28 at 10:56 a.m. EDT.

These research-and-development leaders have an edge on their competitors.

6.

Dykstra: Diving In Headfirst

by Lenny Dykstra, published March 28 at 9:49 a.m. EDT.

These two positions have reached new buy levels.

7.

Sorting Through the Clintons' Finances

by Aaron Task, published March 26 at 7:31 a.m. EDT.

Once again, the former president's entanglements cast a long shadow on his wife.

8.

Stockpickr: Check Out These Dow Laggards

by James Altucher, published March 28 at 8:06 a.m. EDT.

These solid Dow stocks are down 'century to date.'

9.

Kass: The Simple Math of Subprime's Slide

by Doug Kass, published March 26 at 1:12 p.m. EDT.

A look at the numbers reveals more trouble for housing.

10.

Wednesday's Health Winners & Losers

by Robert Holmes, published March 28 at 4:38 p.m. EDT.

Vertex Pharmaceuticals is up.

David Morrow is editor-in-chief of TheStreet.com. In keeping with TSC's editorial policy, he doesn't own or short individual stocks, though he owns stock in TheStreet.com. He also doesn't invest in hedge funds or other private investment partnerships. He appreciates your feedback;

click here

to send him an email.